Tsuga, founded by former Datadog product leaders, just secured $10 million in seed funding. The Paris-based startup is taking on the $50B+ observability market with a “bring your own cloud” approach that could disrupt how enterprises monitor AI systems.
Anthropic reportedly expects to reach $70 billion in revenue by 2028, up from around $5 billion this year. The AI startup also anticipates becoming cash flow positive by 2027, three years ahead of OpenAI’s projections. Meanwhile, research shows AI-human collaboration boosts output by 60% while reduc
The managed service provider collective just added three more companies to its portfolio and plans to dramatically accelerate its acquisition pace. CEO Tim Conkle believes they can do up to 40 deals per year while expanding their member network from 175 to 600 MSPs.
Tim Cook’s 65th birthday has reignited speculation about Apple’s CEO succession plan. With Jeff Williams out, John Ternus emerges as the frontrunner while dark horse Sabih Khan gains momentum. The timing suggests Cook wants to launch one more major product before stepping down.
European startups are scaling abroad due to a critical late-stage funding gap. With €15 trillion locked in pension funds, the continent faces an innovation exodus that could reshape global tech leadership.
Goldman Sachs’ latest conviction list reveals five stocks with explosive growth potential, from Korean gaming to hydrogen technology. These picks signal where smart money sees the biggest opportunities in 2025’s evolving markets.
Twin sisters Taylor Capuano and Casey Sarai started Cakes Body with just $10,000 in personal savings. Within three years, their simple solution for wardrobe malfunctions generated $95 million in net sales. Here’s what their explosive growth reveals about modern entrepreneurship.
Atlassian’s $610 million acquisition of Dia represents a major bet on AI browsers. The Browser Company is now applying lessons from Arc’s failure to create a more accessible AI-native browsing experience.
Seattle venture firm Founders’ Co-op has secured $50 million for its sixth fund, maintaining its focused strategy of backing Pacific Northwest founders at the earliest stages. The firm, known for early investments in Remitly and Auth0, continues betting on technical founders over specific verticals.
Stockholm-based BOOST Pharma has raised €3.1 million from Sound Bioventures to accelerate clinical development of BT-101, a pioneering stem cell therapy for children with brittle bone disease. The investment reflects Europe’s growing commitment to advanced cell therapies for rare pediatric condition
